scholarly journals Advanced treatment line (ATL) with lenvatinib and everolimus (Len+Eve) for metastatic renal cell carcinoma (mRCC): Analysis of a national early access program (EAP)

2018 ◽  
Vol 29 ◽  
pp. viii318
Author(s):  
A. Peer ◽  
M. Kolin ◽  
K. Rouvinov ◽  
D. Keizman ◽  
D. Sarid ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Treatment ◽  
Treatment Line ◽  
Early Access ◽  
Access Program

scholarly journals Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

2021 ◽  
Vol 142 ◽  
pp. 102-111
Author(s):  
Laurence Albiges ◽  
Aude Fléchon ◽  
Christine Chevreau ◽  
Delphine Topart ◽  
Gwenaëlle Gravis ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Early Access ◽  
Real World Evidence ◽  
Access Program

REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis

2015 ◽  
Vol 11 (21) ◽  
pp. 2893-2903 ◽  
Author(s):  
Sergio Bracarda ◽  
Sylvie Rottey ◽  
Amit Bahl ◽  
Christian Eichelberg ◽  
Begoña Mellado ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Real World ◽  
Renal Cell ◽  
Real World Data ◽  
World Data ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program

scholarly journals Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)

2018 ◽  
Vol 29 ◽  
pp. viii317
Author(s):  
A. Gomez de Liano Lista ◽  
B. Venugopal ◽  
K. Fife ◽  
S. Symeonides ◽  
N.S. Vasudev ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Expanded Access ◽  
Expanded Access Program ◽  
Access Program
Sign in / Sign up

Export Citation Format

Share Document